You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Bulk Pharmaceutical API Sources for PERCORTEN


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PERCORTEN

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ⤷  Get Started Free 3001 ⤷  Get Started Free
MP Biomedicals ⤷  Get Started Free 101497 ⤷  Get Started Free
MolPort ⤷  Get Started Free MolPort-001-785-923 ⤷  Get Started Free
ABI Chem ⤷  Get Started Free AC1L1EY8 ⤷  Get Started Free
ChemMol ⤷  Get Started Free 49425888 ⤷  Get Started Free
Finetech Industry Limited ⤷  Get Started Free FT-0603103 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for PERCORTEN

Last updated: July 27, 2025


Introduction

Percorten, the commercial name for Depo-Medrol, contains the active ingredient methylprednisolone acetate, a potent corticosteroid widely used in veterinary medicine to treat inflammatory and immune-mediated conditions in animals. The quality, safety, and consistency of methylprednisolone acetate as an API are critical for its therapeutic efficacy and regulatory compliance. This article examines the primary sources of bulk methylprednisolone acetate APIs, highlighting their manufacturing profiles, regulatory standing, and supply chain considerations for pharmaceutical companies and veterinary medicine providers.


Overview of Methylprednisolone Acetate as an API

Methylprednisolone acetate is a synthetic glucocorticoid with anti-inflammatory, immunosuppressive, and metabolic effects. Its pharmaceutical applications extend across multiple sectors, with veterinary uses like Percorten being prominent. The API's quality standards are governed by strict pharmacopeial monographs such as the USP, EP, and JP, dictating specifications for purity, stability, and potency. Ensuring consistent API sourcing from reputable manufacturers is vital for maintaining drug efficacy and compliance.


Major API Manufacturers and Suppliers

1. European Manufacturers

a. Dr. Renner GmbH & Co. KG
A prominent German API producer with extensive experience in corticosteroid manufacturing, including methylprednisolone acetate. Renner adheres to strict European Good Manufacturing Practice (GMP) standards, providing APIs compliant with EMA regulations. Their manufacturing facilities are certified for high-quality bulk production suitable for both human and veterinary medicines [1].

b. Synthesis and Chemical Companies in Germany and France
Other European players include companies specializing in steroid synthesis, such as Sanofi and Roche, leveraging their extensive R&D and manufacturing infrastructure. These firms often supply APIs either directly or through authorized distributors, with high emphasis on purity and consistency.

2. Asian API Suppliers

a. Zhejiang Hisun Pharmaceutical Co., Ltd. (China)
A leading Chinese API manufacturer with an established portfolio for corticosteroids, including methylprednisolone acetate. Hisun's GMP-compliant plants service international markets, with exports regulated by global health authorities.

b. Jiangsu Hengrui Medicine Co., Ltd.
Another Chinese pharmaceutical power with robust corticosteroid API production, Hengrui maintains rigorous quality control and has received approvals from regulatory bodies like the FDA and EMA for several products, indicating high manufacturing standards [2].

c. Indian Manufacturers (e.g., Sun Pharmaceutical Industries Ltd., Lupin Ltd.)
Indian pharmaceutical companies, notably Sun Pharma and Lupin, produce corticosteroid APIs, including methylprednisolone acetate, often aimed at both domestic and export markets. These firms comply with WHO-GMP standards and frequently register their APIs with major regulatory authorities [3].

3. North American API Suppliers

a. Pfizer Inc.
While Pfizer is primarily known for finished dosage forms, its manufacturing facilities also produce APIs under stringent regulations. The company supplies methylprednisolone acetate APIs that meet US pharmacopeial standards.

b. Other US-based API Producers
Several smaller US-based API manufacturers specialize in corticosteroids, though their capacity for large-scale supplies may be limited compared to international giants.


Criteria for Selecting API Suppliers

  • Regulatory Compliance: Suppliers should possess valid GMP certifications from recognized authorities (EMA, FDA, TGA, etc.).

  • Quality Assurance: Consistent batch quality, documentation, and stability data.

  • Scale and Capacity: Ability to meet large-volume demands for veterinary products like Percorten.

  • Supply Chain Security: Proven reliability for timely delivery and risk mitigation.

  • Cost Considerations: Competitive pricing balanced with quality expectations.


Regulatory and Quality Considerations

The API must align with pharmacopeial standards to ensure safety and efficacy. Suppliers compliant with international standards like USP, EP, or JP provide greater assurance during regulatory filings and product approval processes. For veterinary APIs like methylprednisolone acetate used in Percorten, regulatory agencies may have specific requirements, including Certificates of Analysis (CoA), stability profiles, and antimicrobial testing.


Emerging Trends and Market Dynamics

  • Manufacturing Diversification: Companies increasingly diversify sources to mitigate supply chain disruptions, especially amid geopolitical tensions and pandemic-related supply chain interruptions.

  • Vertical Integration: Some pharmaceutical companies are adopting integrated strategies, controlling both API manufacturing and finished product formulation to enhance quality oversight.

  • Regulatory Harmonization: Harmonization efforts between agencies like the FDA and EMA facilitate smoother registration and acceptance of APIs from different regions.

  • Green Chemistry Practices: New manufacturers focus on sustainable manufacturing processes to reduce environmental impact, aligning with global regulatory expectations.


Risks and Challenges in API Sourcing

  • Quality Variability: Inconsistent API quality can impact drug efficacy and safety, necessitating robust supplier qualification processes.

  • Regulatory Approvals: Variations in regulatory acceptance for APIs from different regions may influence sourcing decisions.

  • Supply Chain Disruptions: Political, logistical, or environmental factors can interrupt supply, emphasizing the importance of multiple qualified suppliers.

  • Cost Fluctuations: Market demand and raw material prices can influence API costs, affecting the final product pricing.


Conclusion

The supply of methylprednisolone acetate API essential for Percorten production hinges on reputable manufacturers across Europe, Asia, and North America. Leading European suppliers like Dr. Renner provide high-quality APIs conforming to stringent standards, while Asian manufacturers like Zhejiang Hisun and Jiangsu Hengrui offer scalable, cost-effective options with regulatory compliance. North American suppliers such as Pfizer complement the global sourcing landscape. Strategic supplier qualification, adherence to regulatory standards, and supply chain resilience remain pivotal for ensuring consistent, high-quality API supply for veterinary pharmaceuticals like Percorten.


Key Takeaways

  • Diverse sourcing options exist globally, with reputable European, Asian, and North American manufacturers supplying methylprednisolone acetate APIs.

  • Regulatory compliance (GMP, pharmacopeial standards) is crucial for ensuring API quality, safety, and efficacy.

  • Supply chain resilience and quality assurance protocols mitigate risks of shortages and quality variability in API procurement.

  • Emerging sustainable manufacturing practices contribute positively toward environmental goals and regulatory acceptance.

  • Thorough supplier qualification and oversight are essential to maintain manufacturing integrity and regulatory compliance in veterinary pharmaceutical production.


FAQs

  1. What are the primary regions supplying methylprednisolone acetate APIs for veterinary use?
    Europe, China, India, and North America are the leading regions, offering a range of reputable API manufacturers with GMP certification and global distribution capabilities.

  2. How do I verify an API supplier's regulatory compliance?
    Review their GMP certification, Certificates of Analysis, validation documentation, and regulatory approvals from agencies like EMA, FDA, or WHO. Engaging third-party audits or inspections enhances due diligence.

  3. Can APIs from different regions be used interchangeably for Percorten manufacturing?
    Potentially, but only if they meet identical quality and purity standards, and their sourcing aligns with regulatory approvals for the specific formulation.

  4. What are the key quality parameters for methylprednisolone acetate APIs?
    Purity (>98%), potency, stability, residual solvents, microbial limits, and compliance with pharmacopeial standards.

  5. What risks are associated with sourcing APIs from developing countries?
    Risks include variability in quality control, regulatory acceptance challenges, supply disruptions, and intellectual property concerns. Due diligence and supplier qualification are essential.


References

[1] European Medicines Agency. (2022). Guidelines on Good Manufacturing Practice.
[2] Hengrui Medicine. (2021). Annual Report and Regulatory Documentation.
[3] Sun Pharmaceutical Industries Ltd. (2022). API Manufacturing and Quality Assurance.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.